nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—Alzheimer's disease	0.399	1	CbGaD
Lenalidomide—CDH5—blood vessel—Alzheimer's disease	0.0139	0.162	CbGeAlD
Lenalidomide—TNFSF11—embryo—Alzheimer's disease	0.011	0.129	CbGeAlD
Lenalidomide—CDH5—embryo—Alzheimer's disease	0.00829	0.0969	CbGeAlD
Lenalidomide—CRBN—embryo—Alzheimer's disease	0.00526	0.0616	CbGeAlD
Lenalidomide—CRBN—forebrain—Alzheimer's disease	0.00466	0.0545	CbGeAlD
Lenalidomide—CRBN—telencephalon—Alzheimer's disease	0.00428	0.0501	CbGeAlD
Lenalidomide—CDH5—nervous system—Alzheimer's disease	0.00398	0.0465	CbGeAlD
Lenalidomide—CDH5—central nervous system—Alzheimer's disease	0.00383	0.0448	CbGeAlD
Lenalidomide—CDH5—cerebellum—Alzheimer's disease	0.00374	0.0438	CbGeAlD
Lenalidomide—CDH5—brain—Alzheimer's disease	0.00304	0.0356	CbGeAlD
Lenalidomide—CRBN—nervous system—Alzheimer's disease	0.00253	0.0296	CbGeAlD
Lenalidomide—Pomalidomide—TNF—Alzheimer's disease	0.0025	0.338	CrCbGaD
Lenalidomide—CRBN—central nervous system—Alzheimer's disease	0.00243	0.0285	CbGeAlD
Lenalidomide—PTGS2—blood vessel—Alzheimer's disease	0.0024	0.0281	CbGeAlD
Lenalidomide—CRBN—cerebellum—Alzheimer's disease	0.00238	0.0278	CbGeAlD
Lenalidomide—CRBN—brain—Alzheimer's disease	0.00193	0.0226	CbGeAlD
Lenalidomide—Thalidomide—TNF—Alzheimer's disease	0.00161	0.218	CrCbGaD
Lenalidomide—ABCB1—blood vessel—Alzheimer's disease	0.00149	0.0174	CbGeAlD
Lenalidomide—PTGS2—embryo—Alzheimer's disease	0.00143	0.0168	CbGeAlD
Lenalidomide—Thalidomide—PTGS1—Alzheimer's disease	0.00134	0.181	CrCbGaD
Lenalidomide—PTGS2—forebrain—Alzheimer's disease	0.00127	0.0148	CbGeAlD
Lenalidomide—Pomalidomide—PTGS2—Alzheimer's disease	0.00119	0.16	CrCbGaD
Lenalidomide—PTGS2—telencephalon—Alzheimer's disease	0.00117	0.0136	CbGeAlD
Lenalidomide—ABCB1—embryo—Alzheimer's disease	0.000887	0.0104	CbGeAlD
Lenalidomide—ABCB1—forebrain—Alzheimer's disease	0.000784	0.00917	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—Alzheimer's disease	0.000764	0.103	CrCbGaD
Lenalidomide—ABCB1—telencephalon—Alzheimer's disease	0.000721	0.00843	CbGeAlD
Lenalidomide—PTGS2—nervous system—Alzheimer's disease	0.000688	0.00805	CbGeAlD
Lenalidomide—PTGS2—central nervous system—Alzheimer's disease	0.000663	0.00775	CbGeAlD
Lenalidomide—PTGS2—cerebellum—Alzheimer's disease	0.000648	0.00758	CbGeAlD
Lenalidomide—PTGS2—brain—Alzheimer's disease	0.000526	0.00615	CbGeAlD
Lenalidomide—ABCB1—nervous system—Alzheimer's disease	0.000426	0.00498	CbGeAlD
Lenalidomide—ABCB1—central nervous system—Alzheimer's disease	0.00041	0.00479	CbGeAlD
Lenalidomide—ABCB1—cerebellum—Alzheimer's disease	0.000401	0.00469	CbGeAlD
Lenalidomide—ABCB1—brain—Alzheimer's disease	0.000325	0.00381	CbGeAlD
Lenalidomide—Rhinitis—Rivastigmine—Alzheimer's disease	0.000261	0.000668	CcSEcCtD
Lenalidomide—Skin disorder—Galantamine—Alzheimer's disease	0.000261	0.000668	CcSEcCtD
Lenalidomide—Urethral disorder—Memantine—Alzheimer's disease	0.000261	0.000668	CcSEcCtD
Lenalidomide—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000261	0.000666	CcSEcCtD
Lenalidomide—Hepatitis—Rivastigmine—Alzheimer's disease	0.000261	0.000666	CcSEcCtD
Lenalidomide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00026	0.000665	CcSEcCtD
Lenalidomide—Hallucination—Rivastigmine—Alzheimer's disease	0.000259	0.000663	CcSEcCtD
Lenalidomide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000259	0.000663	CcSEcCtD
Lenalidomide—Alopecia—Donepezil—Alzheimer's disease	0.000259	0.000663	CcSEcCtD
Lenalidomide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000259	0.000661	CcSEcCtD
Lenalidomide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000257	0.000658	CcSEcCtD
Lenalidomide—Mental disorder—Donepezil—Alzheimer's disease	0.000257	0.000657	CcSEcCtD
Lenalidomide—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000257	0.000657	CcSEcCtD
Lenalidomide—Visual impairment—Memantine—Alzheimer's disease	0.000257	0.000657	CcSEcCtD
Lenalidomide—Anorexia—Galantamine—Alzheimer's disease	0.000256	0.000656	CcSEcCtD
Lenalidomide—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000256	0.000655	CcSEcCtD
Lenalidomide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000256	0.000653	CcSEcCtD
Lenalidomide—Malnutrition—Donepezil—Alzheimer's disease	0.000255	0.000653	CcSEcCtD
Lenalidomide—Erythema—Donepezil—Alzheimer's disease	0.000255	0.000653	CcSEcCtD
Lenalidomide—Erythema multiforme—Memantine—Alzheimer's disease	0.000252	0.000644	CcSEcCtD
Lenalidomide—Flatulence—Donepezil—Alzheimer's disease	0.000252	0.000644	CcSEcCtD
Lenalidomide—Hypotension—Galantamine—Alzheimer's disease	0.000251	0.000643	CcSEcCtD
Lenalidomide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000251	0.000642	CcSEcCtD
Lenalidomide—Tension—Donepezil—Alzheimer's disease	0.000251	0.000641	CcSEcCtD
Lenalidomide—Dysgeusia—Donepezil—Alzheimer's disease	0.00025	0.00064	CcSEcCtD
Lenalidomide—Eye disorder—Memantine—Alzheimer's disease	0.000249	0.000637	CcSEcCtD
Lenalidomide—Tinnitus—Memantine—Alzheimer's disease	0.000248	0.000635	CcSEcCtD
Lenalidomide—Nervousness—Donepezil—Alzheimer's disease	0.000248	0.000634	CcSEcCtD
Lenalidomide—Flushing—Memantine—Alzheimer's disease	0.000247	0.000632	CcSEcCtD
Lenalidomide—Cardiac disorder—Memantine—Alzheimer's disease	0.000247	0.000632	CcSEcCtD
Lenalidomide—Back pain—Donepezil—Alzheimer's disease	0.000247	0.000632	CcSEcCtD
Lenalidomide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000246	0.00063	CcSEcCtD
Lenalidomide—Muscle spasms—Donepezil—Alzheimer's disease	0.000246	0.000628	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000245	0.000627	CcSEcCtD
Lenalidomide—Eye disorder—Rivastigmine—Alzheimer's disease	0.000244	0.000623	CcSEcCtD
Lenalidomide—Insomnia—Galantamine—Alzheimer's disease	0.000243	0.000622	CcSEcCtD
Lenalidomide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000243	0.000621	CcSEcCtD
Lenalidomide—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000242	0.000619	CcSEcCtD
Lenalidomide—Flushing—Rivastigmine—Alzheimer's disease	0.000242	0.000619	CcSEcCtD
Lenalidomide—Angiopathy—Memantine—Alzheimer's disease	0.000242	0.000618	CcSEcCtD
Lenalidomide—Paraesthesia—Galantamine—Alzheimer's disease	0.000242	0.000618	CcSEcCtD
Lenalidomide—Vision blurred—Donepezil—Alzheimer's disease	0.000241	0.000616	CcSEcCtD
Lenalidomide—Immune system disorder—Memantine—Alzheimer's disease	0.000241	0.000615	CcSEcCtD
Lenalidomide—Mediastinal disorder—Memantine—Alzheimer's disease	0.00024	0.000614	CcSEcCtD
Lenalidomide—Tremor—Donepezil—Alzheimer's disease	0.000239	0.000612	CcSEcCtD
Lenalidomide—Somnolence—Galantamine—Alzheimer's disease	0.000239	0.000611	CcSEcCtD
Lenalidomide—Chills—Memantine—Alzheimer's disease	0.000239	0.000611	CcSEcCtD
Lenalidomide—Arrhythmia—Memantine—Alzheimer's disease	0.000238	0.000609	CcSEcCtD
Lenalidomide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000237	0.000606	CcSEcCtD
Lenalidomide—Dyspepsia—Galantamine—Alzheimer's disease	0.000237	0.000605	CcSEcCtD
Lenalidomide—Angiopathy—Rivastigmine—Alzheimer's disease	0.000236	0.000605	CcSEcCtD
Lenalidomide—Anaemia—Donepezil—Alzheimer's disease	0.000236	0.000604	CcSEcCtD
Lenalidomide—Alopecia—Memantine—Alzheimer's disease	0.000235	0.000602	CcSEcCtD
Lenalidomide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000235	0.000601	CcSEcCtD
Lenalidomide—Agitation—Donepezil—Alzheimer's disease	0.000235	0.0006	CcSEcCtD
Lenalidomide—Chills—Rivastigmine—Alzheimer's disease	0.000234	0.000598	CcSEcCtD
Lenalidomide—Decreased appetite—Galantamine—Alzheimer's disease	0.000234	0.000598	CcSEcCtD
Lenalidomide—Mental disorder—Memantine—Alzheimer's disease	0.000233	0.000597	CcSEcCtD
Lenalidomide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000233	0.000595	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000232	0.000594	CcSEcCtD
Lenalidomide—Malnutrition—Memantine—Alzheimer's disease	0.000232	0.000593	CcSEcCtD
Lenalidomide—Fatigue—Galantamine—Alzheimer's disease	0.000232	0.000593	CcSEcCtD
Lenalidomide—Malaise—Donepezil—Alzheimer's disease	0.00023	0.000589	CcSEcCtD
Lenalidomide—Alopecia—Rivastigmine—Alzheimer's disease	0.00023	0.000589	CcSEcCtD
Lenalidomide—Constipation—Galantamine—Alzheimer's disease	0.00023	0.000588	CcSEcCtD
Lenalidomide—Vertigo—Donepezil—Alzheimer's disease	0.00023	0.000587	CcSEcCtD
Lenalidomide—Syncope—Donepezil—Alzheimer's disease	0.000229	0.000586	CcSEcCtD
Lenalidomide—Flatulence—Memantine—Alzheimer's disease	0.000229	0.000584	CcSEcCtD
Lenalidomide—Mental disorder—Rivastigmine—Alzheimer's disease	0.000228	0.000584	CcSEcCtD
Lenalidomide—Tension—Memantine—Alzheimer's disease	0.000228	0.000582	CcSEcCtD
Lenalidomide—Dysgeusia—Memantine—Alzheimer's disease	0.000227	0.000581	CcSEcCtD
Lenalidomide—Erythema—Rivastigmine—Alzheimer's disease	0.000227	0.00058	CcSEcCtD
Lenalidomide—Malnutrition—Rivastigmine—Alzheimer's disease	0.000227	0.00058	CcSEcCtD
Lenalidomide—Nervousness—Memantine—Alzheimer's disease	0.000225	0.000576	CcSEcCtD
Lenalidomide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000225	0.000574	CcSEcCtD
Lenalidomide—Back pain—Memantine—Alzheimer's disease	0.000224	0.000574	CcSEcCtD
Lenalidomide—Flatulence—Rivastigmine—Alzheimer's disease	0.000224	0.000572	CcSEcCtD
Lenalidomide—Cough—Donepezil—Alzheimer's disease	0.000223	0.00057	CcSEcCtD
Lenalidomide—Tension—Rivastigmine—Alzheimer's disease	0.000223	0.000569	CcSEcCtD
Lenalidomide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000222	0.000568	CcSEcCtD
Lenalidomide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000222	0.000567	CcSEcCtD
Lenalidomide—Hypertension—Donepezil—Alzheimer's disease	0.000221	0.000564	CcSEcCtD
Lenalidomide—Nervousness—Rivastigmine—Alzheimer's disease	0.00022	0.000563	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00022	0.000562	CcSEcCtD
Lenalidomide—Back pain—Rivastigmine—Alzheimer's disease	0.000219	0.000561	CcSEcCtD
Lenalidomide—Vision blurred—Memantine—Alzheimer's disease	0.000219	0.000559	CcSEcCtD
Lenalidomide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000218	0.000558	CcSEcCtD
Lenalidomide—Chest pain—Donepezil—Alzheimer's disease	0.000217	0.000556	CcSEcCtD
Lenalidomide—Myalgia—Donepezil—Alzheimer's disease	0.000217	0.000556	CcSEcCtD
Lenalidomide—Arthralgia—Donepezil—Alzheimer's disease	0.000217	0.000556	CcSEcCtD
Lenalidomide—Tremor—Memantine—Alzheimer's disease	0.000217	0.000556	CcSEcCtD
Lenalidomide—Anxiety—Donepezil—Alzheimer's disease	0.000217	0.000554	CcSEcCtD
Lenalidomide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000215	0.00055	CcSEcCtD
Lenalidomide—Discomfort—Donepezil—Alzheimer's disease	0.000215	0.000549	CcSEcCtD
Lenalidomide—Anaemia—Memantine—Alzheimer's disease	0.000214	0.000548	CcSEcCtD
Lenalidomide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000214	0.000547	CcSEcCtD
Lenalidomide—Agitation—Memantine—Alzheimer's disease	0.000213	0.000545	CcSEcCtD
Lenalidomide—Dry mouth—Donepezil—Alzheimer's disease	0.000213	0.000544	CcSEcCtD
Lenalidomide—Body temperature increased—Galantamine—Alzheimer's disease	0.000213	0.000544	CcSEcCtD
Lenalidomide—Abdominal pain—Galantamine—Alzheimer's disease	0.000213	0.000544	CcSEcCtD
Lenalidomide—Tremor—Rivastigmine—Alzheimer's disease	0.000213	0.000544	CcSEcCtD
Lenalidomide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000211	0.000538	CcSEcCtD
Lenalidomide—Confusional state—Donepezil—Alzheimer's disease	0.00021	0.000537	CcSEcCtD
Lenalidomide—Anaemia—Rivastigmine—Alzheimer's disease	0.00021	0.000536	CcSEcCtD
Lenalidomide—Malaise—Memantine—Alzheimer's disease	0.000209	0.000535	CcSEcCtD
Lenalidomide—Agitation—Rivastigmine—Alzheimer's disease	0.000209	0.000533	CcSEcCtD
Lenalidomide—Oedema—Donepezil—Alzheimer's disease	0.000208	0.000533	CcSEcCtD
Lenalidomide—Vertigo—Memantine—Alzheimer's disease	0.000208	0.000533	CcSEcCtD
Lenalidomide—Syncope—Memantine—Alzheimer's disease	0.000208	0.000532	CcSEcCtD
Lenalidomide—Leukopenia—Memantine—Alzheimer's disease	0.000208	0.000531	CcSEcCtD
Lenalidomide—Infection—Donepezil—Alzheimer's disease	0.000207	0.00053	CcSEcCtD
Lenalidomide—Shock—Donepezil—Alzheimer's disease	0.000205	0.000524	CcSEcCtD
Lenalidomide—Palpitations—Memantine—Alzheimer's disease	0.000205	0.000524	CcSEcCtD
Lenalidomide—Malaise—Rivastigmine—Alzheimer's disease	0.000205	0.000523	CcSEcCtD
Lenalidomide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000204	0.000523	CcSEcCtD
Lenalidomide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000204	0.000522	CcSEcCtD
Lenalidomide—Vertigo—Rivastigmine—Alzheimer's disease	0.000204	0.000521	CcSEcCtD
Lenalidomide—Loss of consciousness—Memantine—Alzheimer's disease	0.000204	0.000521	CcSEcCtD
Lenalidomide—Syncope—Rivastigmine—Alzheimer's disease	0.000203	0.00052	CcSEcCtD
Lenalidomide—Cough—Memantine—Alzheimer's disease	0.000202	0.000517	CcSEcCtD
Lenalidomide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000202	0.000515	CcSEcCtD
Lenalidomide—Palpitations—Rivastigmine—Alzheimer's disease	0.000201	0.000513	CcSEcCtD
Lenalidomide—Hypertension—Memantine—Alzheimer's disease	0.0002	0.000512	CcSEcCtD
Lenalidomide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000199	0.00051	CcSEcCtD
Lenalidomide—Anorexia—Donepezil—Alzheimer's disease	0.000199	0.000508	CcSEcCtD
Lenalidomide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000198	0.000507	CcSEcCtD
Lenalidomide—Cough—Rivastigmine—Alzheimer's disease	0.000198	0.000506	CcSEcCtD
Lenalidomide—Chest pain—Memantine—Alzheimer's disease	0.000197	0.000505	CcSEcCtD
Lenalidomide—Myalgia—Memantine—Alzheimer's disease	0.000197	0.000505	CcSEcCtD
Lenalidomide—Arthralgia—Memantine—Alzheimer's disease	0.000197	0.000505	CcSEcCtD
Lenalidomide—Anxiety—Memantine—Alzheimer's disease	0.000197	0.000503	CcSEcCtD
Lenalidomide—Hypertension—Rivastigmine—Alzheimer's disease	0.000196	0.000501	CcSEcCtD
Lenalidomide—Discomfort—Memantine—Alzheimer's disease	0.000195	0.000499	CcSEcCtD
Lenalidomide—Hypotension—Donepezil—Alzheimer's disease	0.000195	0.000498	CcSEcCtD
Lenalidomide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000193	0.000494	CcSEcCtD
Lenalidomide—Myalgia—Rivastigmine—Alzheimer's disease	0.000193	0.000494	CcSEcCtD
Lenalidomide—Chest pain—Rivastigmine—Alzheimer's disease	0.000193	0.000494	CcSEcCtD
Lenalidomide—Dry mouth—Memantine—Alzheimer's disease	0.000193	0.000494	CcSEcCtD
Lenalidomide—Asthenia—Galantamine—Alzheimer's disease	0.000193	0.000493	CcSEcCtD
Lenalidomide—Anxiety—Rivastigmine—Alzheimer's disease	0.000193	0.000492	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000192	0.000491	CcSEcCtD
Lenalidomide—Confusional state—Memantine—Alzheimer's disease	0.000191	0.000488	CcSEcCtD
Lenalidomide—Discomfort—Rivastigmine—Alzheimer's disease	0.000191	0.000488	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00019	0.000486	CcSEcCtD
Lenalidomide—Oedema—Memantine—Alzheimer's disease	0.000189	0.000484	CcSEcCtD
Lenalidomide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000189	0.000483	CcSEcCtD
Lenalidomide—Insomnia—Donepezil—Alzheimer's disease	0.000189	0.000482	CcSEcCtD
Lenalidomide—Infection—Memantine—Alzheimer's disease	0.000188	0.000481	CcSEcCtD
Lenalidomide—Paraesthesia—Donepezil—Alzheimer's disease	0.000187	0.000479	CcSEcCtD
Lenalidomide—Confusional state—Rivastigmine—Alzheimer's disease	0.000187	0.000477	CcSEcCtD
Lenalidomide—Shock—Memantine—Alzheimer's disease	0.000186	0.000476	CcSEcCtD
Lenalidomide—Dyspnoea—Donepezil—Alzheimer's disease	0.000186	0.000475	CcSEcCtD
Lenalidomide—Nervous system disorder—Memantine—Alzheimer's disease	0.000186	0.000475	CcSEcCtD
Lenalidomide—Somnolence—Donepezil—Alzheimer's disease	0.000185	0.000474	CcSEcCtD
Lenalidomide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000185	0.000474	CcSEcCtD
Lenalidomide—Oedema—Rivastigmine—Alzheimer's disease	0.000185	0.000473	CcSEcCtD
Lenalidomide—Tachycardia—Memantine—Alzheimer's disease	0.000185	0.000472	CcSEcCtD
Lenalidomide—Diarrhoea—Galantamine—Alzheimer's disease	0.000184	0.000471	CcSEcCtD
Lenalidomide—Infection—Rivastigmine—Alzheimer's disease	0.000184	0.00047	CcSEcCtD
Lenalidomide—Skin disorder—Memantine—Alzheimer's disease	0.000184	0.00047	CcSEcCtD
Lenalidomide—Dyspepsia—Donepezil—Alzheimer's disease	0.000184	0.000469	CcSEcCtD
Lenalidomide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000183	0.000468	CcSEcCtD
Lenalidomide—Shock—Rivastigmine—Alzheimer's disease	0.000182	0.000466	CcSEcCtD
Lenalidomide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000182	0.000464	CcSEcCtD
Lenalidomide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000181	0.000464	CcSEcCtD
Lenalidomide—Decreased appetite—Donepezil—Alzheimer's disease	0.000181	0.000463	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—SOD1—Alzheimer's disease	0.000181	0.00155	CbGpPWpGaD
Lenalidomide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000181	0.000462	CcSEcCtD
Lenalidomide—Anorexia—Memantine—Alzheimer's disease	0.00018	0.000461	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00018	0.00046	CcSEcCtD
Lenalidomide—Skin disorder—Rivastigmine—Alzheimer's disease	0.00018	0.00046	CcSEcCtD
Lenalidomide—Fatigue—Donepezil—Alzheimer's disease	0.00018	0.00046	CcSEcCtD
Lenalidomide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000179	0.000458	CcSEcCtD
Lenalidomide—Constipation—Donepezil—Alzheimer's disease	0.000178	0.000456	CcSEcCtD
Lenalidomide—Pain—Donepezil—Alzheimer's disease	0.000178	0.000456	CcSEcCtD
Lenalidomide—Dizziness—Galantamine—Alzheimer's disease	0.000178	0.000455	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000178	0.00152	CbGpPWpGaD
Lenalidomide—Hypotension—Memantine—Alzheimer's disease	0.000177	0.000452	CcSEcCtD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000177	0.00151	CbGpPWpGaD
Lenalidomide—Anorexia—Rivastigmine—Alzheimer's disease	0.000177	0.000451	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—PSEN2—Alzheimer's disease	0.000176	0.0015	CbGpPWpGaD
Lenalidomide—Hypotension—Rivastigmine—Alzheimer's disease	0.000173	0.000442	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000172	0.000441	CcSEcCtD
Lenalidomide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000172	0.000439	CcSEcCtD
Lenalidomide—Insomnia—Memantine—Alzheimer's disease	0.000171	0.000438	CcSEcCtD
Lenalidomide—Vomiting—Galantamine—Alzheimer's disease	0.000171	0.000437	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00017	0.000436	CcSEcCtD
Lenalidomide—PTGS2—Overview of nanoparticle effects—IL6—Alzheimer's disease	0.00017	0.00145	CbGpPWpGaD
Lenalidomide—Paraesthesia—Memantine—Alzheimer's disease	0.00017	0.000435	CcSEcCtD
Lenalidomide—Rash—Galantamine—Alzheimer's disease	0.00017	0.000434	CcSEcCtD
Lenalidomide—Dermatitis—Galantamine—Alzheimer's disease	0.000169	0.000433	CcSEcCtD
Lenalidomide—Dyspnoea—Memantine—Alzheimer's disease	0.000169	0.000431	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000169	0.000431	CcSEcCtD
Lenalidomide—Headache—Galantamine—Alzheimer's disease	0.000169	0.000431	CcSEcCtD
Lenalidomide—Somnolence—Memantine—Alzheimer's disease	0.000168	0.00043	CcSEcCtD
Lenalidomide—Insomnia—Rivastigmine—Alzheimer's disease	0.000167	0.000428	CcSEcCtD
Lenalidomide—Dyspepsia—Memantine—Alzheimer's disease	0.000167	0.000426	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000166	0.00142	CbGpPWpGaD
Lenalidomide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000166	0.000425	CcSEcCtD
Lenalidomide—Urticaria—Donepezil—Alzheimer's disease	0.000166	0.000423	CcSEcCtD
Lenalidomide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000165	0.000422	CcSEcCtD
Lenalidomide—Abdominal pain—Donepezil—Alzheimer's disease	0.000165	0.000421	CcSEcCtD
Lenalidomide—Body temperature increased—Donepezil—Alzheimer's disease	0.000165	0.000421	CcSEcCtD
Lenalidomide—Somnolence—Rivastigmine—Alzheimer's disease	0.000165	0.000421	CcSEcCtD
Lenalidomide—Decreased appetite—Memantine—Alzheimer's disease	0.000165	0.000421	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000163	0.000418	CcSEcCtD
Lenalidomide—Fatigue—Memantine—Alzheimer's disease	0.000163	0.000417	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—SOD2—Alzheimer's disease	0.000163	0.00139	CbGpPWpGaD
Lenalidomide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000163	0.000417	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—NPY—Alzheimer's disease	0.000162	0.00138	CbGpPWpGaD
Lenalidomide—Constipation—Memantine—Alzheimer's disease	0.000162	0.000414	CcSEcCtD
Lenalidomide—Pain—Memantine—Alzheimer's disease	0.000162	0.000414	CcSEcCtD
Lenalidomide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000161	0.000412	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IAPP—Alzheimer's disease	0.000161	0.00137	CbGpPWpGaD
Lenalidomide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00016	0.000409	CcSEcCtD
Lenalidomide—Nausea—Galantamine—Alzheimer's disease	0.00016	0.000409	CcSEcCtD
Lenalidomide—Fatigue—Rivastigmine—Alzheimer's disease	0.00016	0.000408	CcSEcCtD
Lenalidomide—Pain—Rivastigmine—Alzheimer's disease	0.000158	0.000405	CcSEcCtD
Lenalidomide—Constipation—Rivastigmine—Alzheimer's disease	0.000158	0.000405	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CRH—Alzheimer's disease	0.000156	0.00133	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Memantine—Alzheimer's disease	0.000156	0.000399	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.000156	0.00133	CbGpPWpGaD
Lenalidomide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000155	0.000396	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—NGFR—Alzheimer's disease	0.000155	0.00132	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000154	0.00131	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000154	0.000393	CcSEcCtD
Lenalidomide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000153	0.00039	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000151	0.000387	CcSEcCtD
Lenalidomide—Urticaria—Memantine—Alzheimer's disease	0.00015	0.000384	CcSEcCtD
Lenalidomide—Abdominal pain—Memantine—Alzheimer's disease	0.00015	0.000383	CcSEcCtD
Lenalidomide—Body temperature increased—Memantine—Alzheimer's disease	0.00015	0.000383	CcSEcCtD
Lenalidomide—Asthenia—Donepezil—Alzheimer's disease	0.00015	0.000382	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000149	0.00127	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NPS—Alzheimer's disease	0.000148	0.00126	CbGpPWpGaD
Lenalidomide—Pruritus—Donepezil—Alzheimer's disease	0.000147	0.000377	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000147	0.00126	CbGpPWpGaD
Lenalidomide—Urticaria—Rivastigmine—Alzheimer's disease	0.000147	0.000376	CcSEcCtD
Lenalidomide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000146	0.000374	CcSEcCtD
Lenalidomide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000146	0.000374	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—PTK2B—Alzheimer's disease	0.000145	0.00124	CbGpPWpGaD
Lenalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Alzheimer's disease	0.000145	0.00124	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	0.000144	0.00123	CbGpPWpGaD
Lenalidomide—Diarrhoea—Donepezil—Alzheimer's disease	0.000143	0.000365	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—GAB2—Alzheimer's disease	0.000141	0.00121	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SST—Alzheimer's disease	0.000141	0.00121	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NTRK2—Alzheimer's disease	0.000141	0.00121	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GSK3A—Alzheimer's disease	0.00014	0.0012	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.00014	0.00119	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Memantine—Alzheimer's disease	0.000139	0.000357	CcSEcCtD
Lenalidomide—Dizziness—Donepezil—Alzheimer's disease	0.000138	0.000352	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—APP—Alzheimer's disease	0.000138	0.00118	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000137	0.00117	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000136	0.000349	CcSEcCtD
Lenalidomide—Asthenia—Memantine—Alzheimer's disease	0.000136	0.000347	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—BDNF—Alzheimer's disease	0.000135	0.00115	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000135	0.00115	CbGpPWpGaD
Lenalidomide—Pruritus—Memantine—Alzheimer's disease	0.000134	0.000342	CcSEcCtD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Alzheimer's disease	0.000134	0.00114	CbGpPWpGaD
Lenalidomide—Asthenia—Rivastigmine—Alzheimer's disease	0.000133	0.00034	CcSEcCtD
Lenalidomide—Vomiting—Donepezil—Alzheimer's disease	0.000133	0.000339	CcSEcCtD
Lenalidomide—Rash—Donepezil—Alzheimer's disease	0.000131	0.000336	CcSEcCtD
Lenalidomide—Dermatitis—Donepezil—Alzheimer's disease	0.000131	0.000336	CcSEcCtD
Lenalidomide—Pruritus—Rivastigmine—Alzheimer's disease	0.000131	0.000335	CcSEcCtD
Lenalidomide—Headache—Donepezil—Alzheimer's disease	0.000131	0.000334	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—PLCB1—Alzheimer's disease	0.00013	0.00111	CbGpPWpGaD
Lenalidomide—Diarrhoea—Memantine—Alzheimer's disease	0.00013	0.000331	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1A—Alzheimer's disease	0.000129	0.0011	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000129	0.0011	CbGpPWpGaD
Lenalidomide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000127	0.000324	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—IL1A—Alzheimer's disease	0.000126	0.00108	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—F2—Alzheimer's disease	0.000126	0.00108	CbGpPWpGaD
Lenalidomide—Dizziness—Memantine—Alzheimer's disease	0.000125	0.00032	CcSEcCtD
Lenalidomide—Nausea—Donepezil—Alzheimer's disease	0.000124	0.000317	CcSEcCtD
Lenalidomide—Dizziness—Rivastigmine—Alzheimer's disease	0.000122	0.000313	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000122	0.00104	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NGFR—Alzheimer's disease	0.000121	0.00104	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000121	0.00103	CbGpPWpGaD
Lenalidomide—Vomiting—Memantine—Alzheimer's disease	0.00012	0.000308	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00012	0.00102	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000119	0.00102	CbGpPWpGaD
Lenalidomide—Rash—Memantine—Alzheimer's disease	0.000119	0.000305	CcSEcCtD
Lenalidomide—Dermatitis—Memantine—Alzheimer's disease	0.000119	0.000305	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.000119	0.00102	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000119	0.00101	CbGpPWpGaD
Lenalidomide—Headache—Memantine—Alzheimer's disease	0.000119	0.000303	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—ADAM10—Alzheimer's disease	0.000118	0.00101	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000118	0.00101	CbGpPWpGaD
Lenalidomide—Vomiting—Rivastigmine—Alzheimer's disease	0.000118	0.000301	CcSEcCtD
Lenalidomide—Rash—Rivastigmine—Alzheimer's disease	0.000117	0.000299	CcSEcCtD
Lenalidomide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000117	0.000298	CcSEcCtD
Lenalidomide—Headache—Rivastigmine—Alzheimer's disease	0.000116	0.000297	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—INS—Alzheimer's disease	0.000114	0.000975	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	0.000114	0.000973	CbGpPWpGaD
Lenalidomide—Nausea—Memantine—Alzheimer's disease	0.000112	0.000287	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CCL2—Alzheimer's disease	0.000112	0.000959	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—S100B—Alzheimer's disease	0.000112	0.000956	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.000111	0.000949	CbGpPWpGaD
Lenalidomide—Nausea—Rivastigmine—Alzheimer's disease	0.00011	0.000281	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000109	0.000931	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IGF2—Alzheimer's disease	0.000107	0.00091	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000106	0.000904	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—LEP—Alzheimer's disease	0.000106	0.000902	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	0.000104	0.000887	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IGF1R—Alzheimer's disease	0.000103	0.00088	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.000102	0.000874	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—BCL2—Alzheimer's disease	0.0001	0.000854	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	9.9e-05	0.000845	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—LPL—Alzheimer's disease	9.88e-05	0.000844	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS2—Alzheimer's disease	9.85e-05	0.000841	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MEF2C—Alzheimer's disease	9.8e-05	0.000836	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	9.72e-05	0.00083	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Alzheimer's disease	9.71e-05	0.000829	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PRKCG—Alzheimer's disease	9.61e-05	0.000821	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ITM2B—Alzheimer's disease	9.46e-05	0.000808	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NGF—Alzheimer's disease	9.36e-05	0.000799	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	9.15e-05	0.000781	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR5—Alzheimer's disease	9.11e-05	0.000778	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HTR2A—Alzheimer's disease	8.91e-05	0.000761	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	8.88e-05	0.000758	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	8.61e-05	0.000736	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	8.52e-05	0.000727	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	8.51e-05	0.000727	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	8.47e-05	0.000723	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CALM1—Alzheimer's disease	8.31e-05	0.00071	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	8.31e-05	0.00071	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—LEP—Alzheimer's disease	8.29e-05	0.000707	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APOE—Alzheimer's disease	8.29e-05	0.000707	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CAV1—Alzheimer's disease	8.21e-05	0.000701	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DHCR24—Alzheimer's disease	7.92e-05	0.000676	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ESR1—Alzheimer's disease	7.91e-05	0.000675	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—F2—Alzheimer's disease	7.81e-05	0.000667	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NOTCH1—Alzheimer's disease	7.65e-05	0.000653	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GAPDHS—Alzheimer's disease	7.56e-05	0.000646	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	7.39e-05	0.000631	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GSK3B—Alzheimer's disease	7.18e-05	0.000613	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CREB1—Alzheimer's disease	7.12e-05	0.000608	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—INS—Alzheimer's disease	7.08e-05	0.000604	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	7.07e-05	0.000603	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL2—Alzheimer's disease	6.96e-05	0.000595	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	6.86e-05	0.000586	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IGF1—Alzheimer's disease	6.85e-05	0.000585	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	6.74e-05	0.000575	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CA4—Alzheimer's disease	6.74e-05	0.000575	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	6.72e-05	0.000574	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	6.58e-05	0.000562	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	6.58e-05	0.000562	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	6.57e-05	0.000561	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TTR—Alzheimer's disease	6.56e-05	0.00056	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	6.49e-05	0.000554	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	6.43e-05	0.000549	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	6.33e-05	0.000541	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NOS3—Alzheimer's disease	6.21e-05	0.00053	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	6.18e-05	0.000528	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	6.17e-05	0.000527	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	6.03e-05	0.000515	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	6e-05	0.000513	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	5.94e-05	0.000507	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLD3—Alzheimer's disease	5.73e-05	0.000489	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.73e-05	0.000489	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.66e-05	0.000483	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DHCR24—Alzheimer's disease	5.62e-05	0.000479	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	5.57e-05	0.000476	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	5.49e-05	0.000469	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.37e-05	0.000458	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	5.29e-05	0.000451	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CASP3—Alzheimer's disease	5.27e-05	0.00045	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	5.23e-05	0.000447	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	5.18e-05	0.000443	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	5.11e-05	0.000437	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ND1—Alzheimer's disease	5.1e-05	0.000436	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.99e-05	0.000426	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	4.99e-05	0.000426	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	4.89e-05	0.000417	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SNCA—Alzheimer's disease	4.87e-05	0.000416	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.86e-05	0.000415	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAPK8—Alzheimer's disease	4.84e-05	0.000414	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	4.78e-05	0.000408	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CA4—Alzheimer's disease	4.77e-05	0.000408	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.57e-05	0.00039	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.56e-05	0.00039	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	4.49e-05	0.000383	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—VEGFA—Alzheimer's disease	4.47e-05	0.000382	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	4.44e-05	0.000379	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	4.38e-05	0.000374	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PSENEN—Alzheimer's disease	4.34e-05	0.000371	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	4.31e-05	0.000368	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APH1A—Alzheimer's disease	4.28e-05	0.000366	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	4.26e-05	0.000363	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.21e-05	0.000359	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	4.2e-05	0.000359	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NCSTN—Alzheimer's disease	4.17e-05	0.000356	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	4.11e-05	0.000351	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TGFB1—Alzheimer's disease	4.1e-05	0.00035	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LRP1—Alzheimer's disease	4.07e-05	0.000347	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLD3—Alzheimer's disease	4.06e-05	0.000347	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	3.94e-05	0.000337	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.93e-05	0.000336	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TPI1—Alzheimer's disease	3.93e-05	0.000335	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	3.89e-05	0.000332	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.88e-05	0.000331	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.77e-05	0.000322	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	3.75e-05	0.00032	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—EIF2AK2—Alzheimer's disease	3.69e-05	0.000315	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.68e-05	0.000314	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GAPDH—Alzheimer's disease	3.62e-05	0.000309	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ND1—Alzheimer's disease	3.62e-05	0.000309	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.58e-05	0.000306	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.56e-05	0.000304	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.49e-05	0.000298	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PSEN2—Alzheimer's disease	3.39e-05	0.000289	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TP53—Alzheimer's disease	3.38e-05	0.000288	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.32e-05	0.000284	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CST3—Alzheimer's disease	3.32e-05	0.000283	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CHAT—Alzheimer's disease	3.29e-05	0.000281	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TPI1—Alzheimer's disease	3.29e-05	0.000281	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.24e-05	0.000277	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MAOB—Alzheimer's disease	3.15e-05	0.000269	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IAPP—Alzheimer's disease	3.1e-05	0.000265	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—Alzheimer's disease	3.09e-05	0.000264	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GAPDH—Alzheimer's disease	3.04e-05	0.000259	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3e-05	0.000256	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.98e-05	0.000254	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.97e-05	0.000254	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—A2M—Alzheimer's disease	2.93e-05	0.00025	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.93e-05	0.00025	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ENO1—Alzheimer's disease	2.85e-05	0.000244	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AKT1—Alzheimer's disease	2.85e-05	0.000244	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPP3CA—Alzheimer's disease	2.84e-05	0.000242	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.75e-05	0.000235	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GAB2—Alzheimer's disease	2.72e-05	0.000232	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GSK3A—Alzheimer's disease	2.7e-05	0.00023	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APP—Alzheimer's disease	2.65e-05	0.000227	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.64e-05	0.000225	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.61e-05	0.000223	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ACHE—Alzheimer's disease	2.55e-05	0.000218	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.52e-05	0.000216	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—INPP5D—Alzheimer's disease	2.52e-05	0.000215	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.48e-05	0.000211	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ENO1—Alzheimer's disease	2.39e-05	0.000204	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PTGS1—Alzheimer's disease	2.39e-05	0.000204	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.36e-05	0.000201	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	2.34e-05	0.0002	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.33e-05	0.000199	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.33e-05	0.000199	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ADAM10—Alzheimer's disease	2.28e-05	0.000195	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MAOB—Alzheimer's disease	2.24e-05	0.000191	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—BCHE—Alzheimer's disease	2.22e-05	0.00019	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.15e-05	0.000184	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLCB1—Alzheimer's disease	2.1e-05	0.000179	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—A2M—Alzheimer's disease	2.08e-05	0.000177	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.08e-05	0.000177	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCA1—Alzheimer's disease	2.03e-05	0.000174	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LPL—Alzheimer's disease	1.9e-05	0.000163	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRKCG—Alzheimer's disease	1.85e-05	0.000158	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.81e-05	0.000154	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.79e-05	0.000153	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.75e-05	0.00015	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CCR5—Alzheimer's disease	1.75e-05	0.00015	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.75e-05	0.00015	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.74e-05	0.000149	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTHFR—Alzheimer's disease	1.71e-05	0.000146	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.69e-05	0.000145	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.69e-05	0.000145	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.66e-05	0.000142	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CALM1—Alzheimer's disease	1.6e-05	0.000137	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOE—Alzheimer's disease	1.6e-05	0.000136	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPL—Alzheimer's disease	1.59e-05	0.000136	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CAV1—Alzheimer's disease	1.58e-05	0.000135	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.58e-05	0.000134	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—Alzheimer's disease	1.49e-05	0.000127	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.49e-05	0.000127	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOTCH1—Alzheimer's disease	1.47e-05	0.000126	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.44e-05	0.000123	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTHFR—Alzheimer's disease	1.44e-05	0.000123	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GSK3B—Alzheimer's disease	1.38e-05	0.000118	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CREB1—Alzheimer's disease	1.37e-05	0.000117	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—INS—Alzheimer's disease	1.36e-05	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CALM1—Alzheimer's disease	1.34e-05	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOE—Alzheimer's disease	1.34e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAV1—Alzheimer's disease	1.32e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.24e-05	0.000106	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.24e-05	0.000106	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—Alzheimer's disease	1.2e-05	0.000102	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARG—Alzheimer's disease	1.16e-05	9.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—INS—Alzheimer's disease	1.14e-05	9.75e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPL—Alzheimer's disease	1.13e-05	9.65e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.02e-05	8.69e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—Alzheimer's disease	1e-05	8.55e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CALM1—Alzheimer's disease	9.51e-06	8.12e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOE—Alzheimer's disease	9.48e-06	8.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAV1—Alzheimer's disease	9.39e-06	8.02e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARG—Alzheimer's disease	8.25e-06	7.05e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—INS—Alzheimer's disease	8.09e-06	6.91e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—Alzheimer's disease	7.91e-06	6.75e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—Alzheimer's disease	7.1e-06	6.06e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—Alzheimer's disease	6.49e-06	5.54e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—Alzheimer's disease	5.96e-06	5.09e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT1—Alzheimer's disease	5.5e-06	4.69e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKT1—Alzheimer's disease	4.6e-06	3.93e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKT1—Alzheimer's disease	3.26e-06	2.79e-05	CbGpPWpGaD
